• Personal Stories

‘I constantly see research improving outcomes for patients’ – Richard’s story

Three years ago, Richard was diagnosed with testicular cancer, and was treated with surgery, radiotherapy and chemotherapy. Three years ago, Richard was diagnosed with testicular cancer, and was treated with surgery, radiotherapy and chemotherapy.

22 July 2016

• For Researchers

Remarkable PhD student awarded Pontecorvo prize

This year’s Pontecorvo prize for Best PhD Thesis has been awarded to Dr Nicholas McGranahan, an outstanding young scientist at UCL and the Crick. This year’s Pontecorvo prize for Best PhD Thesis has been awarded to Dr Nicholas McGranahan, an outstanding young scientist at UCL and the Crick.

22 July 2016

• Science & Technology
• Health & Medicine

From one-eyed lambs to ‘targeted’ skin cancer drugs

Our scientists have revealed how a targeted skin cancer drug works, which could help tackle drug resistance. Our scientists have revealed how a targeted skin cancer drug works, which could help tackle drug resistance.

21 July 2016

• Personal Stories

“Having cancer made it professional and personal” – Lauren’s story.

Last year Lauren was about to start a year of study abroad in Hong Kong when her mum Julie was diagnosed with breast cancer. Last year Lauren was about to start a year of study abroad in Hong Kong when her mum Julie was diagnosed with breast cancer.

20 July 2016

• Health & Medicine

Tackling hard-to-treat cancers – what, how and why?

Read about how we're approaching the challenge of understanding and treating lung, pancreatic, oesophageal cancers and brain tumours. Read about how we're approaching the challenge of understanding and treating lung, pancreatic, oesophageal cancers and brain tumours.

20 July 2016

• Health & Medicine

Cancer Research UK boosts efforts to overcome deadliest cancer as rates climb

Cancer Research UK has tripled its investment in pancreatic cancer, one of the hardest cancers to treat, since launching its research strategy in 2014. Cancer Research UK has tripled its investment in pancreatic cancer, one of the hardest cancers to treat, since launching its research strategy in 2014.

20 July 2016

• Health & Medicine
• Science & Technology

Making a special case – how to boost brain tumour research

Brain tumours are one of the biggest challenges in cancer research, but we have a plan to tackle them. Brain tumours are one of the biggest challenges in cancer research, but we have a plan to tackle them.

19 July 2016

• Science & Technology

Advances in Wilms’ tumour treatment – how less became more

Find out how our researchers have helped lead to nine in 10 children surviving Wilms' tumour, a type of children's kidney cancer. Find out how our researchers have helped lead to nine in 10 children surviving Wilms' tumour, a type of children's kidney cancer.

19 July 2016

• Health & Medicine

Government’s increase in NHS spending deemed ‘misleading’ according to Health Committee

The Government has been accused of issuing "misleading" figures over its pledge to increase NHS funding. The Government has been accused of issuing "misleading" figures over its pledge to increase NHS funding.

19 July 2016

• Charity News

Last orders on cancer – Dryathlon September is back!

Cancer Research UK’s Dryathlon is challenging the nation to prove their willpower this September. Cancer Research UK’s Dryathlon is challenging the nation to prove their willpower this September.

19 July 2016

• Personal Stories

‘I don’t let anything beat me’ – Keith’s story

Keith Hubbard is just one of the stories featured in our Annual Review, highlighting the progress we’re making and our aims for the future. Keith Hubbard is just one of the stories featured in our Annual Review, highlighting the progress we’re making and our aims for the future.

18 July 2016

• For Researchers

An inspirational mentor and cell signalling pioneer: Chris Marshall

Professor Chris Marshall, who died in August 2015 from the disease he spent his life studying, was one of cancer biology’s most eminent scientists. Professor Chris Marshall, who died in August 2015 from the disease he spent his life studying, was one of cancer biology’s most eminent scientists.

18 July 2016